These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20658525)
1. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation. Guan Y; Yao H; Zheng Z; Qiu G; Sun K Int J Cancer; 2011 May; 128(10):2274-83. PubMed ID: 20658525 [TBL] [Abstract][Full Text] [Related]
2. PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b. Luo S; Wang J; Ma Y; Yao Z; Pan H Biochem Biophys Res Commun; 2015 Jun; 462(2):85-90. PubMed ID: 25944662 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1. Lee M; Kim EJ; Jeon MJ Oncotarget; 2016 Feb; 7(8):8726-42. PubMed ID: 26646586 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700 [TBL] [Abstract][Full Text] [Related]
5. miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1. Guo J; Xia B; Meng F; Lou G Biochem Biophys Res Commun; 2013 Nov; 441(2):357-63. PubMed ID: 24144591 [TBL] [Abstract][Full Text] [Related]
6. MiR-26a promotes ovarian cancer proliferation and tumorigenesis. Shen W; Song M; Liu J; Qiu G; Li T; Hu Y; Liu H PLoS One; 2014; 9(1):e86871. PubMed ID: 24466274 [TBL] [Abstract][Full Text] [Related]
7. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA. Wang Y; Tang Q; Li M; Jiang S; Wang X Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701 [TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue. Giangreco AA; Vaishnav A; Wagner D; Finelli A; Fleshner N; Van der Kwast T; Vieth R; Nonn L Cancer Prev Res (Phila); 2013 May; 6(5):483-94. PubMed ID: 23503652 [TBL] [Abstract][Full Text] [Related]
10. miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide. Jiang Y; Wu Y; Greenlee AR; Wu J; Han Z; Li X; Zhao Y Toxicol Sci; 2011 Jan; 119(1):50-60. PubMed ID: 20889678 [TBL] [Abstract][Full Text] [Related]
11. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366 [TBL] [Abstract][Full Text] [Related]
12. miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells. Jiang H; Qu L; Wang Y; Cong J; Wang W; Yang X Biomed Pharmacother; 2014 Mar; 68(2):163-9. PubMed ID: 24456664 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b. Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Liang L; Wong CM; Ying Q; Fan DN; Huang S; Ding J; Yao J; Yan M; Li J; Yao M; Ng IO; He X Hepatology; 2010 Nov; 52(5):1731-40. PubMed ID: 20827722 [TBL] [Abstract][Full Text] [Related]
15. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745 [TBL] [Abstract][Full Text] [Related]
16. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. Feng B; Wang R; Chen LB Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675 [TBL] [Abstract][Full Text] [Related]
17. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. Liu LH; Li H; Li JP; Zhong H; Zhang HC; Chen J; Xiao T Biochem Biophys Res Commun; 2011 Dec; 416(1-2):31-8. PubMed ID: 22093834 [TBL] [Abstract][Full Text] [Related]
18. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Zhang Y; Yan LX; Wu QN; Du ZM; Chen J; Liao DZ; Huang MY; Hou JH; Wu QL; Zeng MS; Huang WL; Zeng YX; Shao JY Cancer Res; 2011 May; 71(10):3552-62. PubMed ID: 21444677 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression. Zhao A; Zeng Q; Xie X; Zhou J; Yue W; Li Y; Pei X J Genet Genomics; 2012 Jan; 39(1):29-35. PubMed ID: 22293115 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4. Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]